cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Crispr Therapeutics Ag
242 own
88 watching
Current Price
$0
$4.93
(9.42%)
logo-crsp
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
4,094.71M
52-Week High
52-Week High
86.95
52-Week Low
52-Week Low
38.94
Average Volume
Average Volume
1.37M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
16.7148
iconMarket Capitalization4,094.71M
icon52-Week High86.95
icon52-Week Low38.94
iconAverage Volume1.37M
iconDividend Yield--
iconP/E Ratio16.7148
What does the Crispr Therapeutics Ag do?
CRISPR Therapeutics AG focuses on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. The CRISPR/Cas9 technology allows for changes to genomic DNA. The company has strategic collaborations with Bayer AG and Vertex Pharmaceuticals to develop CRISPR-based therapeutics in other diseases. It operates in Switzerland, the United States, and the United Kingdom. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.
Read More
How much money does Crispr Therapeutics Ag make?
News & Events about Crispr Therapeutics Ag.
Globe Newswire
22days ago
ZUG, Switzerland and CAMBRIDGE, Mass., Jan. 11, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to ...
Globe Newswire
1month ago
ZUG, Switzerland and BOSTON, Dec. 19, 2022 (GLOBE NEWSWIRE) -- CRISPR Therapeutics(Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced the appointment of Alex Harding, M.D., M.B.A., as Senior Vice President and Head...
Globe Newswire
1month ago
-Update provided for both Part A (single dose with optional re-dosing) and Part B (consolidation dosing) of the Phase 1 CARBON clinical trial- -Part A data presented at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition confirm that CTX110 can lead to long-term durable ...
Business Wire
1month ago
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced an oral, encore presentation of clinical data from patients with sickle cell disease (SCD) or transfusion-dependent beta-thalassemia (TDT) treated with the investigational therapy exagamglogene...
Globe Newswire
2 months ago
ZUG, Switzerland and BOSTON, Dec. 01, 2022 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in a ...
Frequently Asked Questions
Frequently Asked Questions
What is Crispr Therapeutics Ag share price today?
plus_minus_icon
Can Indians buy Crispr Therapeutics Ag shares?
plus_minus_icon
How can I buy Crispr Therapeutics Ag shares from India?
plus_minus_icon
Can Fractional shares of Crispr Therapeutics Ag be purchased?
plus_minus_icon
What are the documents required to start investing in Crispr Therapeutics Ag stocks?
plus_minus_icon
What is today’s traded volume of Crispr Therapeutics Ag?
plus_minus_icon
What is today’s market capitalisation of Crispr Therapeutics Ag?
plus_minus_icon
What is the 52-Week High and Low Range of Crispr Therapeutics Ag?
plus_minus_icon
What percentage is Crispr Therapeutics Ag down from its 52-Week High?
plus_minus_icon
What percentage is Crispr Therapeutics Ag up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$4.93
(9.42%)
logo-crsp
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
TRANSMEDICS GROUP INC
TRANSMEDICS GROUP INC
$68.21
$2.87 (4.39 %)
AdaptHealth Corp
AdaptHealth Corp
$21.28
$-0.10 (-0.47 %)
Abcam plc
Abcam plc
$15.03
$0.45 (3.09 %)
Inari Medical Inc
Inari Medical Inc
$58.13
$0.73 (1.28 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
TRANSMEDICS GROUP INC
TRANSMEDICS GROUP INC
$68.21
$2.87 (4.39 %)
AdaptHealth Corp
AdaptHealth Corp
$21.28
$-0.10 (-0.47 %)
Abcam plc
Abcam plc
$15.03
$0.45 (3.09 %)
Inari Medical Inc
Inari Medical Inc
$58.13
$0.73 (1.28 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00